Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02481765 · ClinicalTrials.gov registry record · NA
Feasibility and Dose Tolerability of HD-tDCS in Healthy Adults and Children With Down Syndrome
A NA study of Down Syndrome, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- NA
- Development phase
- 5
- Enrollment target
- 1
- Study location
NCT02481765 is a NA study of Down Syndrome that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 5 participants, below the 2,472-participant average among 54 other Down Syndrome trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02481765, a NA study of Down Syndrome, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
- 1
- Study location
Study Summary
Transcranial direct current stimulation (tDCS) is a method which enables noninvasive electrical stimulation of the cortex via electrodes placed on the subject's skull. High definition tDCS (HD-tDCS) allows for precise generation of electrical fields over selected cortical areas using multiple electrodes. The purpose of this pilot trial is to study feasibility, tolerability, and safety of HD-tDCS administered daily for a total of 20 sessions in healthy adults and 5-10 year old children with Down syndrome. PRIMARY OBJECTIVES Part I: To assess feasibility and tolerability of HD-tDCS, administered up to 5 days per week for a total of 20 sessions in healthy adult subjects; Part II: After review of the safety data for Part I is completed and reviewed by the Data Safety Monitoring Committee and IRB, Part II will be initiated. To assess feasibility and tolerability of HD-tDCS, administered up to 5 days per week for a total of 20 sessions in adult subjects with Down Syndrome.
Conditions Studied
Interventions
- DEVICE High definition transcranial direct current stimulation
Study Locations (1)
Wisconsin
- Department of Neurology, University of Wisconsin Madison - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2015-09-15 |
| Est. Completion | 2016-05-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02481765
The ClinicalTrials.gov registry entry for NCT02481765 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,472-participant average among 54 other Down Syndrome trials with a reported enrollment target (100% lower). The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Down Syndrome appearing as the primary indexed condition, and to 1 intervention - of which High definition transcranial direct current stimulation is the first listed.
NCT02481765 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.
Frequently Asked Questions
What is clinical trial NCT02481765 about?
NCT02481765 is a clinical study titled "Feasibility and Dose Tolerability of HD-tDCS in Healthy Adults and Children With Down Syndrome". Transcranial direct current stimulation (tDCS) is a method which enables noninvasive electrical stimulation of the cortex via electrodes placed on the subject's skull. High definition tDCS (HD-tDCS) allows for precise generation of electrical fields over selected cortical areas using multiple electr...
What is the current status of trial NCT02481765?
This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2015-09-15. Estimated completion is 2016-05-20.
What conditions does trial NCT02481765 study?
This clinical trial studies the following conditions: Down Syndrome.
What interventions are being tested in trial NCT02481765?
The interventions under investigation include: High definition transcranial direct current stimulation (DEVICE).
Who is sponsoring clinical trial NCT02481765?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02481765 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Down Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Physical Activity and Community EmPOWERment Project
RECRUITING · NA
-
Treatment of Obstructive Sleep Apnea With Personalized Surgery in Children With Down Syndrome (TOPS-DS)
RECRUITING · NA
-
Brain Outcomes With Lifestyle Change in Down Syndrome
RECRUITING · NA
-
PAP for Children With DS and OSAS
RECRUITING · NA
-
Self-Supporting Nasopharyngeal Airway (ssNPA) Treating Upper Airway Obstruction in Hypotonia
RECRUITING · NA
-
Sleep Intervention and Quality of Life in Down Syndrome
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.